The current meta-analysis indicated that UGT1A1 rs3755319, UGT2B7 rs7662029, and UGT2B7 rs7439366 were significantly associated with AT-DILI risk, and these three SNPs may be used as potential genetic risk markers in anti-TB treatment patients. Here, UGT2B7 is linked to tuberculosis.